<--- Back to Details
First PageDocument Content
Health / Medicine / Breakthrough therapy / Specialty drugs / Gilead Sciences / Healthcare-associated infections / Cyclopropanes / Sofosbuvir / Ledipasvir / National Institute for Health and Care Excellence / Hepatitis / National Health Service
Date: 2016-07-02 14:50:25
Health
Medicine
Breakthrough therapy
Specialty drugs
Gilead Sciences
Healthcare-associated infections
Cyclopropanes
Sofosbuvir
Ledipasvir
National Institute for Health and Care Excellence
Hepatitis
National Health Service

Microsoft Word - GILEAD BRIEFING

Add to Reading List

Source URL: www.ukts.org

Download Document from Source Website

File Size: 102,77 KB

Share Document on Facebook

Similar Documents

CMTF005 - Food is Medicine - Checklist_Debranded

DocID: 1xVMk - View Document

Cardiac electrophysiology / Medical devices / Neuroprosthetics / Medicine / Technology / Computing / Cybernetics / Implantable cardioverter-defibrillator / International Statistical Classification of Diseases and Related Health Problems / Universal Software Radio Peripheral / Artificial cardiac pacemaker / Radio-frequency identification

Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses Daniel Halperin† Thomas S. Heydt-Benjamin†

DocID: 1xVge - View Document

CMTF005 - Food is Medicine - Checklist_Debranded_with bleed

DocID: 1xUza - View Document

CMTF005 - Food is Medicine - Checklist_Debranded_edited

DocID: 1xTtU - View Document

PDF Document

DocID: 1xSqy - View Document